When Purdue Pharmaceuticals released OxyContin in 1996, the company touted its 12-hour pain relief as "more than twice as long as generic medications." But this Los Angeles Times investigation found that the drug wears off early in many patients. Still, instead of stepping back from its 12-hour claim, Purdue told doctors "to prescribe stronger doses, not more frequent ones," which may have helped contribute to OxyContin being "one of the most abused pharmaceuticals in U.S. history."
Migrant students – sometimes fleeing violence – are being routed to alternative programs or being denied access to schools in districts across the country. The AP found instances of students being pushed into separate programs or being dissuaded from enrolling in "at least 35 districts in 14 states."
Dividend arbitrage, or div-arb as it's known, has been an "open secret on Wall Street for years," but a trove of documents reveals how the trading is being used to skirt taxes in more than 20 countries. In Germany alone, div-arb deals mean the government collects $1 billion per year less in taxes than it otherwise would.
Across the country, in-person prison visits are being replaced with video visitation systems – in fact, "over 600 prisons in 46 states have some sort" of the system. And in some places, prisons are getting rid of face-to-face visits altogether in favor of the new technology.
What role did Michigan Gov. Rick Snyder and his administration play in the ongoing public health crisis in Flint? This investigation offers insights into the failures of Snyder and his inner circle to deal with lead-tainted water.
Thank you for your interest in republishing this story. You are are free to republish it so long as you do the following:
You have to credit us. In the byline, we prefer “Author Name, ProPublica.” At the top of the text of your story, include a line that reads: “This story was originally published by ProPublica.” You must link the word “ProPublica” to the original URL of the story.
If you’re republishing online, you must link to the URL of this story on propublica.org, include all of the links from our story, including our newsletter sign up language and link, and use our PixelPing tag.
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week,” and “Portland, Ore.” to “Portland” or “here.”)
You cannot republish our photographs or illustrations without specific permission. Please contact [email protected].
It’s okay to put our stories on pages with ads, but not ads specifically sold against our stories. You can’t state or imply that donations to your organization support ProPublica’s work.
You can’t sell our material separately or syndicate it. This includes publishing or syndicating our work on platforms or apps such as Apple News, Google News, etc.
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually. (To inquire about syndication or licensing opportunities, contact our Vice President of Business Development, Celeste LeCompte.)
You can’t use our work to populate a website designed to improve rankings on search engines or solely to gain revenue from network-based advertisements.
We do not generally permit translation of our stories into another language.
Any website our stories appear on must include a prominent and effective way to contact you.
If you share republished stories on social media, we’d appreciate being tagged in your posts. We have official accounts for ProPublica and ProPublica Illinois on both Twitter (@ProPublica and @ProPublicaIL) and Facebook.
Copy and paste the following into your page to republish: